个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
本科,吉林大学
硕士,吉林大学
博士,德国明斯特大学
主持国家自然科学基金项目
主持北京市自然科学基金项目
主持北京市自然科学基金联合项目
主持国家自然科学基金项目
主持北京市自然科学基金项目
主持北京市自然科学基金联合项目
首都医科大学工作期间发表的文章:
1 Chen Yueyue, Huang Zehuan, Xu Jiang-Fei, Sun Zhiwei, Zhang Xi. (2016) Cytotoxicityregulated by host-guest interactions: a supramolecular strategy to realizecontrolled disguise and exposure. ACS Applied Materials & Interfaces,2016, 8(35), 22780-22784. (被引次数: 74; IF: 10.383; JCR: Q1区)
2 Chen Yueyue, Huang Zehuan, Xu Jiang-Fei, Sun Zhiwei, Zhang Xi. (2017) Supramolecular chemotherapy: cooperative enhancement of antitumor activity by combiningcontrolled release of oxaliplatin and consuming of spermine by cucurbit[7]uril.ACS Applied Materials & Interfaces, 2017, 9(10), 8602-8608. (被引次数: 134; IF: 10.383; JCR: Q1区) 入选2017年ACS Editors' Choice.
2. Chen Hao#,Chen Yueyue#, Wu Han, Xu Jiang-Fei, Sun Zhiwei, Zhang Xi. (2018) Supramolecular polymeric chemotherapy based on cucurbit[7]uril-PEG copolymer. Biomaterials, 2018, 178, 697-705. (被引次数: 68; IF: 15.304; JCR: Q1区; 共同第一作者)
4 Hao Qi#,Chen Yueyue#, Huang Zehuan, Xu Jiang-Fei, Sun Zhiwei, Zhang Xi.(2018) Supramolecular chemotherapy: carboxylated pillar[6]arene for decreasing cytotoxicity of oxaliplatin to normal cells and improving its anticancer bioactivity against colorectal cancer. ACS Applied Materials &Interfaces, 2018, 10(6), 5365-5372. (被引次数: 76; IF: 10.383; JCR: Q1区; 共同第一作者) 入选ESI高被引文章
5 Liang Shuang#, Chen Yueyue#, Zhang Shiming, Cao Yuanyuan, Duan Junchao, Wang Yapei, Sun Zhiwei. (2020) RhB-encapsulating silica nanoparticles modified with PEG impact the vascular endothelial function in endothelial cellsand zebrafish model. Science of the Total Environment, 2020, 711,134493. (IF: 10.753; JCR: Q1区; 共同第一作者)
6 Li Yilin, Chen Yueyue.(2023) Review of noninvasive continuous glucosemonitoring in diabetics. ACS Sensors, 2023. (IF: 9.6; JCR: Q1区; 本科生独立一作)
7 Wang Jiahui#, Zhang Ziyi#, Chen Yueyue. (2023) Supramolecular immunotherapy on diversiform immune cells. Journal of Materials Chemistry B, 2023, 11,8347 - 8367 (IF: 7.4; 本科生第一作者)
8 Li Yilin#,Su Yuteng#, Li Zhaoxiang#, Chen Yueyue. (2022) Supramolecular combination cancertherapy based on macrocyclic supramolecular materials. Polymers, 2022,14, 4855. (JCR: Q1区) Special Issue “New Progress in Polymer Self-Assembly”约稿
9 Zhou Hang,Meng Qingtao, Li Bin, Liu Yikai, Li Zhaoxiang, Li Xiaobo, Sun Zhiwei, ChenYueyue. (2022) Supramolecular combination chemotherapy: cucurbit[8]uril complex enhanced platinum drug infiltration and modified nanomechanical property ofcolorectal cancer cells. Langmuir, 2022, 38, 14326-14334. (本科生独立一作; 入选封面文章)
10 Liu Hanrui, Zhang Xiaoke, Sun Zhiwei, Chen Yueyue. (2023) Ambient fine particulatematter (PM2.5) and cancer: current evidence and future perspectives. Chemical Research in Toxicology, 2023, 36, 141-156. (本科生独立一作)
11 Duan Junchao, Liang Shuang, Yu Yang, Li Yang, Wu Zehao,Chen Yueyue*, Miller Mark R, Sun Zhiwei*. (2018) Inflammation-coagulationresponse and thrombotic effects induced by silica nanoparticles in endothelialcells and zebrafish embryos. Nanotoxicology, 2018, 12(5), 470-484. (JCR:Q1区; 共同通讯作者)
12 Chen Yueyue, Sun Zhiwei. (2020) Supramolecular chemotherapy based on the host-guestcomplex of lobaplatin-cucurbit[7]uril. ACS Applied Bio Materials, 2020,3, 2449-2454.
13 Huang Xin, Zhou Hang, Jiao Rong, Liu Hanrui, Qin Changfu, Xu Lixin, Chen Yueyue.(2021) Supramolecular chemotherapy: host-guest complexes ofheptaplatin-cucurbit[7]uril toward colorectal normal and tumor cells. Langmuir,2021, 37(18), 5475-5482. (本科生第一作者)
14 Chen Yueyue, Jing Li, Meng Qingtao, Li Bin, Chen Rui, Sun Zhiwei. (2021) Noncovalent bond synergy of cucurbit[7]uril against human colorectal tumorcells. Langmuir, 2021, 37(31), 9547-9552.
1 专利名称 超分子联合化疗载药及其制备方法和应用;专利发明人 陈月月、孙志伟、段军超;专利申请号 202210586396.7
2 专利名称 蛋白图案化制备方法;专利发明人 陈月月、迟力峰、斯特凡·舒拉特;专利申请号 202210991575.9
参编推荐性国家标准 纳米技术 基于斑马鱼胚胎的纳米材料毒性评价 标准号:GB/T 42470-2023
中国毒理学会毒理学教育专业委员会青年委员
《毒理学杂志》编委
教育部高等学校科学研究优秀成果奖
讲授《毒理学基础》课程
主持北京市教学项目(大创深化)
主持校级教学项目(第二课堂项目和科研创新项目)
文件上传中...